Prosecution Insights
Prosecution Insights
30 pending office actions • 19 clients • 30 examiners • 22 art units • 0 of 30 (0%) have an AI response strategy ready • 53 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 18 (60%) |
| §102 only | 2 (7%) |
| §112 only | 3 (10%) |
| Double-patenting only | 3 (10%) |
| Double-patenting + other | 1 (3%) |
| No statute on record | 3 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERTAGNA, ANGELA MARIE | 1 | 44.5% | +46.6% |
| JOHNSON, CHRISTOPHER A | 1 | 84.1% | +8.4% |
| KAUFMAN, CLAIRE M | 1 | 63.1% | +51.5% |
| ESKRIDGE, CORY W | 1 | 72.4% | +6.9% |
| ONUTA, TIBERIU DAN | 1 | 75.9% | +24.4% |
| CHAO, ALLEN | 1 | 80.0% | +0.0% |
| JACKSON, SHAWQUIA | 1 | 78.0% | -3.4% |
| PATEL, REEMA | 1 | 88.8% | +6.4% |
| TRAN, TAN N | 1 | 86.7% | +10.0% |
| COLEMAN, BRENDA LIBBY | 1 | 74.7% | +15.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18765338 | METHODS FOR FORMING CONDUCTIVE STRUCTURES BETWEEN TWO SUBSTRATES | JOHNSON, CHRISTOPHER A | — |
| 18293778 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHIC FORMS OF AN ERBB AND BTK INHIBITOR | CHAO, ALLEN | — |
| 18395650 | ELECTRONIC DEVICE AND METHOD FOR MANUFACTURING THE SAME | TRAN, TAN N | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18555250 | MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF | COLEMAN, BRENDA LIBBY | 56d overdue |
| 18731402 | Chimeric Natural Killer Cell Receptors and Method of Using Thereof | KAUFMAN, CLAIRE M | 37d overdue |
| 19236976 | ULTRA SENSITIVE PROBES FOR DETECTING BIOMARKERS | BERTAGNA, ANGELA MARIE | — |
| 18646853 | SEMICONDUCTOR PACKAGE AND METHOD FOR MAKING THE SAME | ONUTA, TIBERIU DAN | — |
| 18395650 | ELECTRONIC DEVICE AND METHOD FOR MANUFACTURING THE SAME | TRAN, TAN N | — |
| Art Unit | Apps |
|---|---|
| 2812 | 3 |
| 1624 | 2 |
| 1644 | 2 |
| 2899 | 2 |
| 1681 | 1 |
| 1674 | 1 |
| 1622 | 1 |
| 1691 | 1 |
| 1621 | 1 |
| 2893 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19236976 | ULTRA SENSITIVE PROBES FOR DETECTING BIOMARKERS | Celnovte Biotechnology, Inc. | BERTAGNA, ANGELA MARIE | 1681 | §103 | Final Rejection | — | Pending | Jun 12, 2025 |
| 18765338 | METHODS FOR FORMING CONDUCTIVE STRUCTURES BETWEEN TWO SUBSTRATES | Stats Chippac Pte. Ltd. | JOHNSON, CHRISTOPHER A | §103 | Non-Final OA | — | Pending | Jul 08, 2024 | |
| 18731402 | Chimeric Natural Killer Cell Receptors and Method of Using Thereof | St Phi Therapeutics Co., Ltd. | KAUFMAN, CLAIRE M | 1674 | §103 | Non-Final OA | 37d overdue | Pending | Jun 03, 2024 |
| 18650077 | SEMICONDUCTOR PACKAGE AND METHOD FOR FORMING THE SAME | Stats Chippac Pte. Ltd. | ESKRIDGE, CORY W | §102 | Non-Final OA | — | Pending | Apr 30, 2024 | |
| 18646853 | SEMICONDUCTOR PACKAGE AND METHOD FOR MAKING THE SAME | Stats Chippac Pte. Ltd. | ONUTA, TIBERIU DAN | §103 | Non-Final OA | — | Pending | Apr 26, 2024 | |
| 18293778 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHIC FORMS OF AN ERBB AND BTK INHIBITOR | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | CHAO, ALLEN | 1622 | DP | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18293337 | DEUTERATED COMPOUNDS | Alebund Pharmaceuticals (Hong Kong) Limited | JACKSON, SHAWQUIA | 1691 | §112 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18395641 | METHOD FOR MAKING A SEMICONDUCTOR DEVICE USING A DOUBLE SIDE MOLDING TECHNOLOGY | Stats Chippac Pte. Ltd. | PATEL, REEMA | 2812 | — | Non-Final OA | — | Pending | Dec 25, 2023 |
| 18395650 | ELECTRONIC DEVICE AND METHOD FOR MANUFACTURING THE SAME | Jcet Stats Chippac Korea Limited | TRAN, TAN N | 2812 | §103 | Non-Final OA | — | Pending | Dec 25, 2023 |
| 18555250 | MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF | Asia Vision Limited | COLEMAN, BRENDA LIBBY | 1624 | §103 | Non-Final OA | 56d overdue | Pending | Oct 12, 2023 |
| 18473282 | ERBB/BTK INHIBITORS | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | SCHMIDT, IZABELA MARIA | 1621 | Other | Non-Final OA | 26d | Pending | Sep 25, 2023 |
| 18469536 | METHOD FOR MAKING AN ELECTRONIC PACKAGE | Jcet Stats Chippac Korea Limited | NETTLES, CORALIE ANN | 2893 | §103 | Non-Final OA | 22d | Pending | Sep 18, 2023 |
| 18460621 | SEMICONDUCTOR DEVICE AND METHOD FOR MAKING THE SAME | Stats Chippac Pte. Ltd. | FAN, SU JYA | 2818 | §103 | Non-Final OA | — | Pending | Sep 04, 2023 |
| 18454785 | BLIND RIVET NUT FOR FIXATION AND SEALING | Pennengineering Automotive Fasteners (Kunshan) Co., Ltd. | SHANSKE, JASON D | 3614 | §103 | Non-Final OA | 53d overdue | Pending | Aug 23, 2023 |
| 18546980 | ANTI-CLDN18.2 ANTIBODY CONJUGATES | BEIJING CANCER HOSPITAL | DUNN, LINDSAY MICHELLE | 1644 | DP | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18447315 | SEMICONDUCTOR DEVICES WITH PYRAMIDAL SHIELDING AND METHOD FOR MAKING THE SAME | Stats Chippac Pte. Ltd. | BULLARD-CONNOR, GENEVIEVE GRACE | 2899 | §103 | Non-Final OA | 9d | Pending | Aug 10, 2023 |
| 18264765 | METHODS OF MODULATING ANDROGEN RECEPTOR CONDENSATES | Etern Biopharma (Shanghai) Co., Ltd. | BELL, SARA ELIZABETH | 1625 | §103 | Non-Final OA | — | Pending | Aug 09, 2023 |
| 18261834 | NOVEL ANTI-GREMLIN1 ANTIBODIES | Suzhou Transcenta Therapeutics Co., Ltd. | JUEDES, AMY E | 1644 | DP | Final Rejection | — | Pending | Jul 17, 2023 |
| 18332777 | MODULAR SEMICONDUCTOR DEVICES AND ELECTRONIC DEVICES INCORPORATING THE SAME | Stats Chippac Pte. Ltd. | VALENZUELA, PATRICIA D | 2812 | §103 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18328795 | METHOD AND APPARATUS FOR FORMING SEMICONDUCTOR DEVICE | Stats Chippac Pte. Ltd. | PARTHASARATHY, ROHIT | 2899 | §103 | Non-Final OA | 16d overdue | Pending | Jun 05, 2023 |
| 18250754 | GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM | Triastek, Inc. | BECKHARDT, LYNDSEY MARIE | 1613 | §103 | Final Rejection | 85d | Pending | Apr 27, 2023 |
| 18246516 | NOVEL ANTI-CLAUDIN18 ANTIBODIES | Elpiscience Biopharma, Ltd. | BERHANE, SELAM | 1675 | §112 | Non-Final OA | 62d | Pending | Mar 24, 2023 |
| 18163884 | SEMICONDUCTOR DEVICE AND METHOD FOR MAKING THE SAME | Stats Chippac Pte. Ltd. | CHANG, JAY C | 2817 | §112 | Non-Final OA | — | Pending | Feb 03, 2023 |
| 18005669 | COMPOSITIONS AND METHODS TO TARGET ANTI-TNF-ALPHA ANTIBODY | Porton Biologics Ltd. | SUNSHINE, HANNAH LOUISE | 1647 | §103 | Non-Final OA | 31d overdue | Pending | Jan 16, 2023 |
| 18066275 | PYRAZINE COMPOUNDS AND USES THEREOF | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | WILLIS, DOUGLAS M | 1624 | Other | Non-Final OA | 55d | Pending | Dec 14, 2022 |
| 17930460 | COMPOSITIONS AND METHODS FOR DIAGNOSING COLORECTAL CANCER | Genegeniedx Corporation | ROSSI, VY BUI | 1685 | §102 | Non-Final OA | 36d | Pending | Sep 08, 2022 |
| 17885578 | ERBB RECEPTOR INHIBITORS | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | HIRAKIS, SOPHIA P | 1623 | §103 | Final Rejection | 23d overdue | Pending | Aug 11, 2022 |
| 17761602 | ATOMIZER | Suzhou Skywell Healthcare Information Co., Ltd. | LEBRON DE JESUS, GRACIELA NATALIA | 3785 | §103 | Final Rejection | — | Pending | Mar 18, 2022 |
| 17636373 | NOVEL ANTI-CLDN18.2 ANTIBODIES | Transcenta Therapeutics, Inc. | SHUPE, ELIZABETH A | 1643 | DPOther | Non-Final OA | 71d | Pending | Feb 18, 2022 |
| 16918958 | HIGH CAPACITY MOLECULE DETECTION | Davinci Bio, Inc. | POHNERT, STEVEN C | 1683 | §103 | Final Rejection | 202d overdue | Pending | Jul 01, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial